Takeda Pharmaceutical Co. has filed to issue up to 500 billion yen ($4.5 billion) of notes in what would be corporate Japan’s biggest ever bond if done in a single tranche.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
